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CONCLUSION: As a reminder, the demand for out-
patient services is deﬁned as current visits to physicians
currently, whereas in the previous OECD studies, it was
deﬁned by the number of visit to physicians (general prac-
titioner) in a certain time period (typically, one year).
Since there is no closer data to the other OECD countries
than CSLSJ in Japan, we have to survey as originally so
as to obtain the completely comparable data even though
it is expensive to do so.
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Obesity has reached epidemic proportions in the U.S. and
studies have shown that counseling obese patients can
have a signiﬁcant impact on the Nation’s health.
OBJECTIVES: The present study aims to assess pharma-
cists’ perceptions about counseling and barriers related to
counseling obese patients.
METHODS: A mail survey was sent to a random sample
of 400 Texas community pharmacists. The questionnaire
was developed using obesity literature and was pretested
among ten community pharmacists. The questionnaire
collected background information of pharmacists and
their perceptions about counseling and barriers to 
counseling. A follow up survey was sent to the 
nonrespondents.
RESULTS: Of the 400 surveys mailed, 139 were returned
completed, six were not usable and ﬁve were undeliver-
able, yielding an overall response rate of 36.7% and a
usable response rate of 35.2%. The pharmacists’ average
age was 49.5 years (SD 13). Most of the pharmacists 
were male (62.6%) and had a bachelor’s degree (94.9%)
as their highest degree. Although pharmacists counseled
obese patients rarely to sometimes, they most often 
counseled about prescribed antiobesity medications and
weight loss through diet and exercise. Pharmacists were
most comfortable counseling patients about self-help
groups and were least comfortable in counseling about
over-the-counter herbal products; however, pharmacists
perceived that the most effective weight loss treatment
was diet and exercise. The two most commonly reported
barriers to counseling obese patients were lack of time
(76.8%) and lack of patient demand (55.8%). Pharma-
cists’ counseling and barriers to counseling differed based
on various background characteristics.
CONCLUSION: Although pharmacists do not counsel
obese patients on a regular basis, they tend to counsel on
issues they are most comfortable with, namely prescribed
antiobesity medications and diet and exercise. Pharma-
cists report lack of time and patient demand as key bar-
riers they face in the community setting.
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Drug-related morbidity (DRM) results in signiﬁcant cost
and consequence. Fifty percent or more of DRM may be
preventable (PDRM). Strategies to reduce the problem of
PDRM need to be identiﬁed in order to improve the
quality of medication use.
OBJECTIVES: (1) To determine the perceived efﬁcacy of
each of eight strategies for reducing PDRM, as expressed
by physicians, and (2) whether this ranking varied
depending upon physician group.
METHODS: Three panels of physicians (twelve general
practitioners [GPs], six geriatricians and six clinical phar-
macologists) who developed and validated quality indi-
cators of PDRM in older adults, received a follow-up mail
survey to identify strategies to reduce PDRM. Each physi-
cian was asked to decide how best to reduce PDRM by
choosing from eight intervention strategies for each
quality indicator their group had developed. For each
indicator, the physician could choose from zero, to all
eight, intervention strategies.
RESULTS: The most commonly chosen strategy per
PDRM indicator was monitoring (72.5%) with health
system management (54.6%) and patient/caregiver coop-
eration (52.1%) second and third, respectively. Monitor-
ing was the most commonly chosen strategy per indicator
by the GPs (81.4%) and the clinical pharmacologists
(64.5%). The geriatricians chose health system manage-
ment most commonly as a strategy per indicator (72.5%).
Overall, an average of 3.95 intervention strategies was
chosen per clinical indicator of PDRM.
CONCLUSIONS: A survey of a group of clinicians
revealed that monitoring is perceived to be the most
important strategy to reduce PDRM among eight inter-
ventions considered. Still, it appears a combination of
intervention strategies is needed to optimally reduce
PDRM. These ﬁndings should serve to guide future
research efforts and health policy aimed at improving the
quality of medication use by minimizing PDRM in older
adults.
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OBJECTIVES: Health outcomes information is being
used more frequently by the pharmaceutical industry to
